World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
47
Citations
7352
World Ranking
6495
National Ranking
181

Mary Chebib publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Mary Chebib sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 164 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Mary Chebib D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Mary Chebib sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 47 D-Index — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Mary Chebib is a researcher affiliated with the University of Sydney in Australia, with a body of work primarily spanning biochemistry, genetics, molecular biology, and neuroscience. Their research integrates molecular biology with neuropharmacology, focusing on mechanisms related to epilepsy, ion channel regulation, and neurodevelopmental disorders.

Their recent scholarly contributions include papers published between 2020 and 2022 in various scientific journals:

  • Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies, 2022, Nature Communications
  • Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy, 2021, Brain
  • Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy, 2021, British Journal of Pharmacology
  • Gain-of-function GABRB3 variants identified in vigabatrin-hypersensitive epileptic encephalopathies, 2020, Brain Communications
  • The Z-Drugs Zolpidem, Zaleplon, and Eszopiclone Have Varying Actions on Human GABAA Receptors Containing γ1, γ2, and γ3 Subunits, 2020, Frontiers in Neuroscience

Mary Chebib has collaborated frequently with several other researchers, including Vivian W. Y. Liao, Philip K. Ahring, Rikke S. Møller, Nathan L. Absalom, and Katrine M. Johannesen. These collaborations suggest active engagement across teams focused on neuropharmacology and genetics related to neurological disorders.

Their publications are often featured in journals specializing in neuroscience and pharmacology. The most frequent venues for their work include:

  • Brain
  • British Journal of Pharmacology
  • Annals of Neurology
  • Neuropharmacology
  • Nature Communications

Mary Chebib's research fields and subfields comprise:

  • Biochemistry, Genetics and Molecular Biology
  • Neuroscience
  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Genetics
  • Psychiatry and Mental health
  • Pharmacology

Their main topics of study cover:

  • Neuroscience and Neuropharmacology Research
  • Epilepsy research and treatment
  • Ion channel regulation and function
  • Nicotinic Acetylcholine Receptors Study
  • Genetics and Neurodevelopmental Disorders
  • RNA and protein synthesis mechanisms
  • Mitochondrial Function and Pathology

Best Publications

  • The 'ABC' of GABA receptors: a brief review.

    Mary Chebib;Graham A R Johnston

  • GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

    Mary Chebib;Graham A. R. Johnston

  • Flavonoid modulation of GABAA receptors

    Jane R. Hanrahan;Mary Chebib;Graham A. R. Johnston

  • The Direct Actions of Cannabidiol and 2-arachidonoyl Glycerol at GABA A Receptors

    T. Bakas;P.S. van Nieuwenhuijzen;S.O. Devenish;I.S. McGregor

  • The dietary flavonoids apigenin and (−)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA receptors

    Erica L. Campbell;Mary Chebib;Graham A.R. Johnston

  • Alpha9 nicotinic acetylcholine receptors and the treatment of pain.

    J. Michael McIntosh;Nathan Absalom;Mary Chebib;Ana Belén Elgoyhen

  • GABAA Receptors and the Diversity in their Structure and Pharmacology.

    Han Chow Chua;Mary Chebib

  • Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactions.

    Lyndsey L. Anderson;Nathan L. Absalom;Sarah V. Abelev;Ivan K. Low

  • The Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice

    Sebastian P. Fernandez;Michael Nguyen;Tin Thing Yow;Cindy Chu

  • Modulation of ionotropic GABA receptors by natural products of plant origin.

    Graham A R Johnston;Jane R Hanrahan;Mary Chebib;Rujee K Duke

  • Contrasting Modes of Action of Methylglutamate Derivatives on the Excitatory Amino Acid Transporters, EAAT1 and EAAT2

    Robert J. Vandenberg;Ann D. Mitrovic;Mary Chebib;Vladimir J. Balcar

  • The β‐amyloid protein of Alzheimer’s disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor

    David Henry Small;Danuta Maria Maksel;M Kerr;Judy Hoi Pui Ng

  • GABAC Receptors as Drug Targets

    Graham A R Johnston;Mary Chebib;Jane R Hanrahan;Kenneth N Mewett

  • α4βδ GABA(A) receptors are high-affinity targets for γ-hydroxybutyric acid (GHB).

    Nathan Absalom;Laura F. Eghorn;Inge S. Villumsen;Nasiara Karim

  • Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies

    Unknown

  • Novel, Potent, and Selective GABAC Antagonists Inhibit Myopia Development and Facilitate Learning and Memory

    Mary Chebib;Tina Hinton;Katrina L. Schmid;Darren Brinkworth

  • Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism.

    Han Chow Chua;Emilie T. H. Christensen;Emilie T. H. Christensen;Kirsten Hoestgaard-Jensen;Leonny Y. Hartiadi

  • Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant α1β2γ2L GABAA receptors

    Shelley H Huang;Rujee K Duke;Mary Chebib;Keiko Sasaki

  • Semisynthetic preparation of amentoflavone: A negative modulator at GABAA receptors

    Jane R. Hanrahan;Mary Chebib;Neil L.M. Davucheron;Belinda J. Hall

  • GABAC RECEPTOR ION CHANNELS

    M Chebib

  • Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors

    Shelley H Huang;Rujee K Duke;Mary Chebib;Keiko Sasaki

  • GABAC receptor antagonists differentiate between human ρ1 and ρ2 receptors expressed in Xenopus oocytes

    Mary Chebib;Kenneth N. Mewett;Graham A.R. Johnston

Frequent Co-Authors

Graham A.R. Johnston
Graham A.R. Johnston University of Sydney
Iain S. McGregor
Iain S. McGregor University of Sydney
Richard B. Silverman
Richard B. Silverman Northwestern University
Marie-Isabel Aguilar
Marie-Isabel Aguilar Monash University
David O'Hagan
David O'Hagan University of St Andrews
David H. Small
David H. Small University of Tasmania
J. Michael McIntosh
J. Michael McIntosh University of Utah
Rikke S. Møller
Rikke S. Møller University of Southern Denmark
Eric J. Gowans
Eric J. Gowans University of Adelaide
Dusan Losic
Dusan Losic University of Adelaide

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in neuroscience doesn’t mean you have to be on campus full-time. Many students are now pursuing an online bachelor's degree in related subjects such as biology, psychology, or healthcare, which allow for greater flexibility. These programs make it easier to balance work, family, and studies while building a strong foundation for a neuroscience pathway.

As the demand for specialized knowledge grows, students often look for the best degrees in the world and seek out the most lucrative college degrees. Neuroscience and its related fields are increasingly recognized for their robust earning potential—especially as graduates can work in research, healthcare, biotech, and pharmaceuticals.

Cost is always a consideration, but there are options to help lower barriers. Look for fafsa-approved online certificate programs to access federal aid and make further education affordable. Whether you are upskilling or starting out, online routes can support a promising future in neuroscience.

Best Scientists Citing Mary Chebib

Trending Scientists

Recently Published Articles